Peraso Inc.
Current- Director 2018 to present
Executive record
Alpha ID: alpha:person:robert-y-newellVersion: public-0As of: 2026-09-29
Robert Y. Newell has served as a member of the board of directors since October 2018 and is currently a consultant and advisor to emerging technology and healthcare companies. He has held financial management positions for companies in Silicon Valley for over 25 years. From 2003 to 2018, he was Chief Financial Officer of Dextera Surgical, Inc., a developer of advanced surgical stapling and medical devices. He previously served as Chief Financial Officer of Omnicell and held executive positions with the Beta Group and Cardiometrics.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
sec filing · Source published: Nov 25, 2025 · Retrieved: May 16, 2026
sec proxy · Source published: Nov 25, 2025 · Retrieved: Apr 25, 2026
public source · Source published: Date unavailable · Retrieved: Date unavailable
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-29